Prostate cancer grading framework based on deep transfer learning and Aquila optimizer

Author:

Balaha Hossam Magdy,Shaban Ahmed Osama,El-Gendy Eman M.ORCID,Saafan Mahmoud M.

Abstract

AbstractProstate cancer is the one of the most dominant cancer among males. It represents one of the leading cancer death causes worldwide. Due to the current evolution of artificial intelligence in medical imaging, deep learning has been successfully applied in diseases diagnosis. However, most of the recent studies in prostate cancer classification suffers from either low accuracy or lack of data. Therefore, the present work introduces a hybrid framework for early and accurate classification and segmentation of prostate cancer using deep learning. The proposed framework consists of two stages, namely classification stage and segmentation stage. In the classification stage, 8 pretrained convolutional neural networks were fine-tuned using Aquila optimizer and used to classify patients of prostate cancer from normal ones. If the patient is diagnosed with prostate cancer, segmenting the cancerous spot from the overall image using U-Net can help in accurate diagnosis, and here comes the importance of the segmentation stage. The proposed framework is trained on 3 different datasets in order to generalize the framework. The best reported classification accuracies of the proposed framework are 88.91% using MobileNet for the “ISUP Grade-wise Prostate Cancer” dataset and 100% using MobileNet and ResNet152 for the “Transverse Plane Prostate Dataset” dataset with precisions 89.22% and 100%, respectively. U-Net model gives an average segmentation accuracy and AUC of 98.46% and 0.9778, respectively, using the “PANDA: Resized Train Data (512 × 512)” dataset. The results give an indicator of the acceptable performance of the proposed framework.

Funder

Mansoura University

Publisher

Springer Science and Business Media LLC

Reference139 articles.

1. Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10(2):63

2. Sung H et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinic 71(3):209–249

3. W (2020) I health organization international agency for research on cancer "health organization international agency for research on cancer (IARC), Globocan 2020 Estimated cancer incidence, mortality, and prevalence on egypt in 2020. https://gco.iarc.fr/today/data/factsheets/populations/818-egypt-fact-sheets.pdf. [Online; accessed 01-Oct-2021]."

4. Cha H-R, Lee JH, Ponnazhagan S (2020) Revisiting immunotherapy: a focus on prostate canceradvances and limitations of immunotherapy in prostate cancer. Can Res 80(8):1615–1623

5. Hoskin P, Neal AJ, Hoskin PJ (2009) Clinical oncology: basic principles and practice. CRC Press, UK

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3